Dalli speaks out passionately for innovation and against PMA system at EU Parliament
This article was originally published in Clinica
European Commissioner for Health and Consumer Policy John Dalli gave an impassioned speech last night at the European Parliament’s plenary session, calling for a measured response to the PIP breast implant scandal, while championing industry’s need to innovate and patients’ needs to have access to innovative products.
You may also be interested in...
It seems to be game over for anyone who might have been hoping the European Commission would do a U-turn on its decision to use the Italian CND nomenclature as the basis for communication in Eudamed, instead of the well-established GMDN. But GMDN is strong in its resolve to remain a vital global nomenclature service.
2020 is not getting off to a good start for manufacturers needing to comply with the EU’s new Medical Device Regulation on 26 May 2020. The European Commission’s latest document seems to confirm industry’s fears about the ability of the EU’s medtech system to be ready in time.
December 2019 was a big month for far-reaching EU medtech regulatory developments that will have a significant impact on the way and speed of implementation of the Medical Device Regulation.